Recce scores $6.75M R&D rebate
Recce Pharmaceuticals (ASX: RCE) has received a cash refund of $6,751,176 Research and Development (R&D) Tax Incentive rebate from the Australian Taxation Office for FY24.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CHP | Ann: Results of Meeting | 28/03/19 | 10 | 920 | |||
|
|||||||
CHP | Ann: Further Amended Appendix 3B | 19/03/19 | 0 | 2.2K | |||
|
|||||||
CHP | Ann: Appendix 3B | 18/03/19 | 4 | 4.1K | |||
|
|||||||
CHP | Ann: Amended Appendix 3B | 17:53 | 0 | 259 | |||
|
|||||||
CHP | Ann: Issue of Rights Issue Shortfall Shares | 15:42 | 3 | 1.3K | |||
|
|||||||
CHP | Ann: Proposal to Voluntarily Delist from ASX | 13/03/19 | 27 | 9.1K | |||
|
|||||||
CHP | Ann: Notice of Extraordinary General Meeting/Proxy Form | 22/02/19 | 0 | 338 | |||
|
|||||||
CHP | News: CHP Chapmans Updates On Proposal To Voluntarily Delist From The ASX | 22/02/19 | 0 | 321 | |||
|
See All Discussions